Comprehensive Genomic Profiling Identifies a Subset of Crizotinib‐Responsive ALK‐Rearranged Non‐Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization

Overview of attention for article published in Oncologist, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 36,387 followers.

RT @montypal: Gr8 collab betw Salgia & @FoundationATCG revealing novel ALK-rearrangements in #lungcancer @cityofhope @OncJournal https://t.…

RT @montypal: Gr8 collab betw Salgia & @FoundationATCG revealing novel ALK-rearrangements in #lungcancer @cityofhope @OncJournal https://t.…

RT @montypal: Gr8 collab betw Salgia & @FoundationATCG revealing novel ALK-rearrangements in #lungcancer @cityofhope @OncJournal https://t.…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.